Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Jaramillo, Sonia
- dc.contributor.author Scherer, Michael
- dc.contributor.author Szu-Tu, Chelsea
- dc.contributor.author Beneyto Calabuig, Sergi
- dc.contributor.author Müller-Tidow, Carsten
- dc.contributor.author Schlenk, Richard F.
- dc.contributor.author Hundemer, Michael
- dc.contributor.author Velten, Lars
- dc.contributor.author Pabst, Caroline
- dc.date.accessioned 2025-01-22T07:24:27Z
- dc.date.available 2025-01-22T07:24:27Z
- dc.date.issued 2024
- dc.format.mimetype application/pdf
- dc.identifier.citation Jaramillo S, Scherer M, Szu-Tu C, Beneyto-Calabuig S, Müller-Tidow C, Schlenk RF, et al. Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib. Haematologica. 2024 Nov 1;109(11):3811-5. DOI: 10.3324/haematol.2023.284922
- dc.identifier.doi http://dx.doi.org/10.3324/haematol.2023.284922
- dc.identifier.issn 0390-6078
- dc.identifier.uri http://hdl.handle.net/10230/69232
- dc.language.iso eng
- dc.publisher Ferrata Storti Foundation
- dc.relation.ispartof Haematologica. 2024 Nov 1;109(11):3811-5
- dc.rights Copyright (c) 2024 Ferrata Storti Foundation. This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/).
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by-nc/4.0/
- dc.subject.other Leucèmia mieloide aguda
- dc.title Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion